| Potential therapeutic options for COVID-19: an update on current evidence Z Niknam, A Jafari, A Golchin, F Danesh Pouya, M Nemati, ... European journal of medical research 27, 1-15, 2022 | 133 | 2022 |
| Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets M Farahani, Z Niknam, LM Amirabad, N Amiri-Dashatan, M Koushki, ... Biomedicine & Pharmacotherapy 145, 112420, 2022 | 105 | 2022 |
| Current advances and challenges in COVID-19 vaccine development: from conventional vaccines to next-generation vaccine platforms A Jafari, F Danesh Pouya, Z Niknam, M Abdollahpour‑Alitappeh, ... Molecular biology reports 49 (6), 4943-4957, 2022 | 34 | 2022 |
| Interaction between DNA damage response and autophagy in colorectal cancer E Roshani-Asl, B Mansori, A Mohammadi, S Najafi, F Danesh-Pouya, ... Gene 730, 144323, 2020 | 16 | 2020 |
| MicroRNAs and drug resistance in colorectal cancer with special focus on 5-fluorouracil FD Pouya, M Gazouli, Y Rasmi, DI Lampropoulou, M Nemati Molecular Biology Reports 49 (6), 5165-5178, 2022 | 12 | 2022 |
| Performance of capecitabine in novel combination therapies in colorectal cancer FD Pouya, Y Rasmi, IY Camci, Y Tutar, M Nemati Journal of Chemotherapy 33 (6), 375-389, 2021 | 12 | 2021 |
| Role of neurotransmitters and neuropeptides in breast cancer metastasis FD Pouya, Y Rasmi, ER Asl Biochemistry (Moscow), Supplement Series A: Membrane and Cell Biology 14 …, 2020 | 11 | 2020 |
| MicroRNAs as therapeutic targets in breast cancer metastasis FD Pouya, Y Rasmi, M Gazouli, E Zografos, M Nemati Drug Delivery and Translational Research 12 (5), 1029-1046, 2022 | 8 | 2022 |
| Curcumin, an inhibitor of PAK1, potential treatment for COVID-19 M Nemati, ER Asl, FD Pouya, Y Rasmi Journal of Infectiology and Epidemiology 3 (2), 2020 | 8 | 2020 |
| Signaling pathways involved in 5-FU drug resistance in cancer F Danesh Pouya, Y Rasmi, M Nemati Cancer Investigation 40 (6), 516-543, 2022 | 6 | 2022 |
| In-vitro study of homocysteine and aspirin effects on fibrinolysis: measuring fibrinolysis parameters J Zavar-Reza, FD Pouya, BA Jalali, F Gholami, ND Pouya Blood Coagulation & Fibrinolysis 25 (1), 1-5, 2014 | 6 | 2014 |
| Vitamin D Double-edged Sword Against COVID-19 FD Pouya, Y Rasmi, M Nemati, ER Asl International Journal of Infection 8 (2), 2021 | 2 | 2021 |
| The combination effects of theophylline and corticosteroids in COVID-19 FD Pouya, M Nemati, ER Asl, Y Rasmi Health Biotechnol Biopharma 4 (3), 1-5, 2020 | 2 | 2020 |
| Parthenolide: suggested drug for COVID-19 M Nemati, Y Rami Инфекция и иммунитет 10 (4), 789-791, 2020 | 2 | 2020 |
| In-vitro study of methylglyoxal and aspirin effects on fibrinolysis parameters FD Pouya, J Zavar-Reza, BA Jalali Blood Coagulation & Fibrinolysis 24 (7), 715-718, 2013 | 2 | 2013 |
| Laboratory methods: A concise review and update for COVID‐19 diagnosis M Nemati, A Jafari, Y Ebrahimi, A Golchin, FD Pouya, M Rezaei‐Tavirani, ... Cell Biochemistry and Function 41 (4), 413-422, 2023 | 1 | 2023 |
| Combination chemotherapy against colorectal cancer cells: Co-delivery of capecitabine and pioglitazone hydrochloride by polycaprolactone-polyethylene glycol carriers FD Pouya, R Salehi, Y Rasmi, F Kheradmand, A Fathi-Azarbayjani Life Sciences 332, 122083, 2023 | | 2023 |
| BAY 11-7082: An Anti-inflammatory Drug for COVID-19 M Nemati, FD Pouya, ER Asl, Y Rasmi Sudan Journal of Medical Sciences 18 (1), 117-120, 2023 | | 2023 |
| Carbon quantum dots may interfere with colorectal cancer treatment through affecting on glutamine metabolism M Nemati, F Danesh Pouya, F Zarein, M Nemati, Y Rasmi, J Rezaie, ... Health Biotechnology and Biopharma (HBB) 6 (2), 1-5, 2022 | | 2022 |
| New insights into the effects of hydroxychloroquine in COVID-19 FD Pouya, Y Rasmi, M Nemati Health Biotechnology and Biopharma, 1-6, 2021 | | 2021 |
Yousef RasmiDepartment of Biochemistry, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran在 umsu.ac.ir 的电子邮件经过验证
